COVID-19 in cancer patients: update from the joint analysis of the ESMO-CoCARE, BSMO, and PSMO international databases

被引：2

作者：

Martin, P. ^{[1
]}

Tsourti, Z. ^{[2
]}

Ribeiro, J. ^{[3
]}

Castelo-Branco, L. ^{[4
,5
]}

de Azambuja, E. ^{[6
]}

Gennatas, S. ^{[7
]}

Rogado, J. ^{[8
]}

Sekacheva, M. ^{[9
]}

Susnjal, S. ^{[10
]}

Vinal, D. ^{[11
]}

Lee, R. ^{[12
,13
]}

Khallaf, S. ^{[14
]}

Dimopoulou, G.

Pradervand, S. ^{[15
]}

Whisenant, J. ^{[16
]}

Choueiri, T. K. ^{[17
,18
]}

Arnold, D. ^{[19
]}

Harrington, K. ^{[20
]}

Punie, K. ^{[21
,22
]}

Oliveira, J. ^{[23
]}

Michielin, O. ^{[15
]}

Dafni, U. ^{[24
]}

Peters, S. ^{[15
]}

Pentheroudakis, G. ^{[5
]}

Romano, E. ^{[1
]}

机构：

[1] Inst Curie, Dept Oncol, Paris, France

[2] Frontier Sci Fdn Hellas, Athens, Greece

[3] Gustave Roussy, Dept Canc Med, Villejuif, France

[4] NOVA Univ, NOVA Natl Sch Publ Hlth, Lisbon, Portugal

[5] ESMO European Soc Med Oncol, Sci & Med Div, Lugano, Switzerland

[6] Univ Libre Bruxelles ULB, Inst Jules Bordet, Brussels, Belgium

[7] Royal Marsden Hosp & NHS Fdn Trust, Med Oncol Dept, London, England

[8] Hosp Univ Infanta Leonor, Med Oncol Dept, Madrid, Spain

[9] Sechenov First Moscow State Med Univ, World Class Res Ctr Digital Biodesign & Personali, Moscow, Russia

[10] Inst Oncol & Radiol Serbia, Dept Med Oncol, Belgrade, Serbia

[11] Hosp Univ La Paz, Med Oncol Dept, Madrid, Spain

[12] Univ Manchester, Fac Biol Med & Hlth, Manchester, England

[13] Christie NHS Fdn Trust, Med Oncol Dept, Manchester, England

[14] Assiut Univ, South Egypt Canc Inst SECI, Med Oncol Dept, Assiut, Egypt

[15] Ctr Hosp Univ Vaudois CHUV, Oncol Dept, Lausanne, Switzerland

[16] Vanderbilt Univ, Med Ctr, Nashville, TN USA

[17] Dana Farber Canc Inst, Lank Ctr Genitourinary Oncol, Boston, MA USA

[18] Harvard Med Sch, Boston, MA USA

[19] Haematol & Palliat Care, Dept Oncol, Tumorzentrum Hamburg, AK Altona, Hamburg, Germany

[20] Royal Marsden Inst Canc Res, NIHR Biomed Res Ctr, Div Radiotherapy & Imaging, London, England

[21] Univ Hosp Leuven, Dept Gen Med Oncol, Leuven, Belgium

[22] Univ Hosp Leuven, Leuven Canc Inst, Multidisciplinary Breast Ctr, Leuven, Belgium

[23] Inst Portugues Oncol Francisco Gentil, Dept Med, Porto, Portugal

[24] Natl & Kapodistrian Univ Athens, Athens Frontier Sci Fdn Hellas, Sch Hlth Sci, Lab Biostat, Athens, Greece

来源：

ESMO OPEN | 2023年 / 8卷 / 03期

关键词：

COVID-19; SARS-CoV-2; cancer; oncology; vaccination; CLINICAL CHARACTERISTICS; ANTICANCER THERAPY; VACCINE; EFFICACY; METAANALYSIS; OUTCOMES; SAFETY;

D O I：

10.1016/j.esmoop.2023.101566

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

101566 higher in symptomatic patients, males, older age, ethnicity other than Asian/Caucasian, Eastern Cooperative Oncology Group performance status >2, body mass index <25, hematological malignancy, progressive disease versus no evident disease, and advanced cancer stage.Conclusions: The updated CoCARE analysis, jointly with BSMO and PSMO, highlights factors that significantly affect COVID-19 outcomes, providing actionable clues for further reducing mortality.

引用

页数：12

共 50 条

[1] COVID-19 in cancer patients: Update from the joint analysis of ESMO-CoCARE, BSMO, PSMO international databases
Romano, E.
Castelo-Branco, L.
Tsourti, Z.
De Azambuja, E.
Gennatas, S.
Oliveira, J.
Rogado, J.
Sekacheva, M.
Susnjar, S.
Vinal Lozano, D.
Lee, R.
Khallaf, S. M.
Dimopoulou, G.
Pradervand, S.
Arnold, D.
Harrington, K. J.
Michielin, O. A.
Dafni, U.
Pentheroudakis, G.
Peters, S.
[J]. ANNALS OF ONCOLOGY, 2022, 33 (07) : S1437 - S1437
[2] COVID-19 in patients with cancer: first report of the ESMO international registry-based, cohort study (ESMO-CoCARE)
Castelo-Branco, L.
Tsourti, Z.
Gennatas, S.
Rogado, J.
Sekacheva, M.
Vinal, D.
Lee, R.
Croitoru, A.
Vitorino, M.
Khallaf, S.
Susnjar, S.
Soewoto, W.
Cardena, A.
Djerouni, M.
Rossi, M.
Alonso-Gordoa, T.
Ngelangel, C.
Whisenant, J. G.
Choueiri, T. K.
Dimopoulou, G.
Pradervand, S.
Arnold, D.
Harrington, K.
Michielin, O.
Dafni, U.
Pentheroudakis, G.
Peters, S.
Romano, E.
[J]. ESMO OPEN, 2022, 7 (03)
[3] COVID-19 and cancer: First report of the ESMO international, registry-based, cohort study (ESMO CoCARE)
Romano, E.
Gennatas, S.
Rogado, J.
Sekacheva, M.
Vinal, D.
Lee, R.
Croitoru, A-E.
Vitorino, M.
Khallaf, S. M.
Susnjar, S.
Widyanti, S.
Cardena, A.
Djerouni, M.
Rossi, M.
Arnold, D.
Castelo-Branco, L.
Harrington, K. J.
Michielin, O. A.
Pentheroudakis, G.
Peters, S.
[J]. ANNALS OF ONCOLOGY, 2021, 32 : S1133 - S1133
[4] Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: a joint analysis of OnCovid and ESMO-CoCARE registries
Cortellini, Alessio
Dettorre, Gino M.
Dafni, Urania
Aguilar-Company, Juan
Castelo-Branco, Luis
Lambertini, Matteo
Gennatas, Spyridon
Angelis, Vasileios
Sita-Lumsden, Ailsa
Rogado, Jacobo
Pedrazzoli, Paolo
Vinal, David
Prat, Aleix
Rossi, Maura
Berardi, Rossana
Alonso-Gordoa, Teresa
Grisanti, Salvatore
Dimopoulou, Georgia
Queirolo, Paola
Pradervand, Sylvain
Bertuzzi, Alexia
Bower, Mark
Arnold, Dirk
Salazar, Ramon
Tucci, Marco
Harrington, Kevin J.
Mazzoni, Francesca
Mukherjee, Uma
Tsourti, Zoi
Michielin, Olivier
Pommeret, Fanny
Brunet, Joan
Vincenzi, Bruno
Tonini, Giuseppe
Patriarca, Andrea
Biello, Federica
Krengli, Marco
Tabernero, Josep
Pentheroudakis, George
Gennari, Alessandra
Peters, Solange
Romano, Emanuela
Pinato, David J.
[J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (11)
[5] Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus
Curigliano, G.
Banerjee, S.
Cervantes, A.
Garassino, M. C.
Garrido, P.
Girard, N.
Haanen, J.
Jordan, K.
Lordick, F.
Machiels, J. P.
Michielin, O.
Peters, S.
Tabernero, J.
Douillard, J. Y.
Pentheroudakis, G.
[J]. ANNALS OF ONCOLOGY, 2020, 31 (10) : 1320 - 1335
[6] Changes in anticancer treatment plans in patients with solid cancer hospitalized with COVID-19: analysis of the nationwide BSMO-COVID registry providing lessons for the future
Geukens, T.
Brandao, M.
Laenen, A.
Collignon, J.
Van Marcke, C.
Louviaux, I.
Demey, W.
Van Wambeke, S.
Schrijvers, D.
Lecomte, S.
Mebis, J.
Rutten, A.
Fontaine, C.
Lybaert, W.
Aspeslagh, S.
Goeminne, J-C
Van Den Bulck, H.
Seront, E.
De Backer, L.
De Roock, W.
Ignatiadis, M.
Prenen, H.
Van Beckhoven, D.
Heijlen, M.
Verheezen, J.
Rottey, S.
Punie, K.
de Azambuja, E.
[J]. ESMO OPEN, 2022, 7 (06)
[7] COVID-19 Update from the NCI Cancer Imaging Program
Eary, Janet
Shankar, Lalitha
[J]. RADIOLOGY-IMAGING CANCER, 2020, 2 (03):
[8] COVID-19 PATIENTS ANALYSIS UTILIZING JAPAN AND US CLAIMS DATABASES
Kim, S. W.
Ishii, T.
Takeno, S.
Kado, Y.
Tamai, Y.
Akiyama, T.
Yu, E.
Demiya, S.
[J]. VALUE IN HEALTH, 2021, 24 : S114 - S114
[9] Life-prolonging treatment restrictions and outcomes in patients with cancer and COVID-19: an update from the Dutch Oncology COVID-19 Consortium
de Joode, Karlijn
Tol, Jolien
Hamberg, Paul
Cloos, Marissa
Kastelijn, Elisabeth A.
Borgers, Jessica S. W.
Nuij, Veerle J. A. A.
Klaver, Yarne
Herder, Gerarda J. M.
Mutsaers, Pim G. N. J.
Dumoulin, Daphne W.
Oomen-de Hoop, Esther
van Diemen, Nico G. J.
Libourel, Eduard J.
Geraedts, Erica J.
Bootsma, Gerben P.
van der Leest, Cor H.
Peerdeman, Anne L.
Herbschleb, Karin H.
Visser, Otto J.
Bloemendal, Haiko J.
van Laarhoven, Hanneke W. M.
de Vries, Elisabeth G. E.
Hendriks, Lizza E. L.
Beerepoot, Laurens, V
Westgeest, Hans M.
van den Berkmortel, Franchette W. P. J.
Haanen, John B. A. G.
Dingemans, Anne-Marie C.
van der Veldt, Astrid A. M.
[J]. EUROPEAN JOURNAL OF CANCER, 2022, 160 : 261 - 272
[10] COVID-19 outcomes in patients with cancer and HIV: An analysis of the COVID-19 and Cancer Consortium (CCC19).
Subbiah, Suki
Islam, Jessica Yasmine
Hennessy, Cassandra
Jiang, Jun Yang
Goyal, Sharad
Vilar-Compte, Diana
Heilman, Hannah
El Zarif, Talal
Farmakiotis, Dimitrios
Accordino, Melissa Kate
Hernandez-Ilizaliturri, Francisco J.
Nguyen, Ryan Huu-Tuan
Castellano, Cecilia A.
Paoluzzi, Luca
Nambiar, Puja
Bashir, Babar
Xie, Zhuoer
Mishra, Sanjay
Warner, Jeremy Lyle
Reid, Erin G.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18790 - E18790

← 1 2 3 4 5 →